Cited by 39Cervical Cancer and HPV ResearchWomen's cancer prevention and managementVaccine Coverage and Hesitancy

Knowledge of Pap smear, HPV and the HPV vaccine and the acceptability of the HPV vaccine by Thai women

CHARAKORN, Chuenkamon, RATTANASIRI, Sasivimol, LERTKHACHONSUK, Arb‐aroon, THANAPPRAPASR, Duangmani, CHITTITHAWORN, Suwicha, WILAILAK, Sarikapan·2011·Asia-Pacific Journal of Clinical Oncology

Abstract

Aims The primary prevention for cervical cancer, a human papilloma virus (HPV) vaccine, has been available in Thailand for almost 3 years. The present study evaluates knowledge about the Papanicolaou (Pap) smear, HPV and the HPV vaccine and focuses on identifying predictors for the acceptability of the HPV vaccine. Methods A sample of 764 women attending the gynecology clinic at Ramathibodi Hospital, Bangkok, was asked to answer a questionnaire on their personal background, their knowledge of the Pap smear and HPV and the HPV vaccine and the acceptability of the HPV vaccine for themselves and their daughters. Results Knowledge of the Pap smear (96%) is higher than that of HPV (41%) and the HPV vaccine (36%). Only 40% of participants had previously heard about HPV. The acceptability of the HPV vaccine for participants and their daughters was high, 77% and 84%, respectively. Knowing about HPV increases acceptance for the HPV vaccine (adjusted OR = 1.7, 95% CI = 1.2-2.5, in the participants and OR = 2.3, 95% CI = 1.5-3.6 in their daughters). Participants younger than 45 years old (OR = 2.3 and 95% CI = 1.6-3.4 for themselves; OR = 2.2 and 95% CI = 1.4-3.3 for their daughters) were more likely to accept the vaccination than those aged 45 years old and above. Conclusion Knowledge about HPV and the HPV vaccine is generally poor in Thai women. However, the acceptability of the HPV vaccine is good. Knowing about HPV and age under 45 years predict the acceptability of the HPV vaccine.

Integrity signals

Registry

Crossref · 10.1111/j.1743-7563.2011.01392.x

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HPV vaccine acceptance in this rural Mysore population was higher than reported among parents in other regions of India (46-74%) and other south Asian countries (26.5-84.0%).

    “There was a higher rate of HPV vaccine acceptance in this population as compared to that reported among parents in the other regions of India (Range: 46% to 74%) 13,14,22 and other countries in south Asia (Range: 26.5% to 84.0%).23-26”
  • A study in Thailand showed lower acceptability of HPV vaccine for daughters among parents older than 45 years compared to those younger than 45.

    “A study in Thailand also showed lower acceptability of HPV vaccine for daughters among parents older than 45 years compared to those younger than 45.24”

Cited by

Sorted by citations

Authors
CHARAKORN, C., RATTANASIRI, S., LERTKHACHONSUK, A., THANAPPRAPASR, D., CHITTITHAWORN, S., & WILAILAK, S.
Affiliations
Mahidol University (TH)
Corresponding author
CHARAKORN, Chuenkamon
Venue
Asia-Pacific Journal of Clinical Oncology
Publisher
Wiley
Published
2011-05-18
Volume
7
Issue
2
Pages
160-167
ISSN
  • 1743-7555 (ISSN-L)
  • 1743-7563
OpenAlex
W1574492921
Cited by
39
References
0
Citations by year
2026: 2 · 2025: 4 · 2024: 1 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 5 · 2018: 5 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 1 · 2013: 2 · 2012: 2
FWCI
1.69
Type
journal article
Language
en
Open access
closed
Locations
  • Asia-Pacific Journal of Clinical Oncology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Merck
Topics
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
Keywords
HPV vaccine, human papillomavirus, Pap smear, vaccine acceptance, health knowledge, cervical cancer prevention, Thai women, age as predictor, vaccine hesitancy
MeSH terms
Adult, Uterine Cervical Neoplasms, Female, Humans, Health Knowledge, Attitudes, Practice, Middle Aged, Patient Acceptance of Health Care, Surveys and Questionnaires, Thailand, Vaginal Smears, Papillomaviridae, Papillomavirus Infections, Papillomavirus Vaccines, Papanicolaou Test

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review